To assess whether this might be a direct effect of mTORC2 activation on DNA methylation, we analyzed global DNA methylation in Rictor (a core component of mTORC2)-knockdown GBM cells with immunofluorescence and dot-blot analyses using a 5-mC antibody. The gene discussed is RICTOR; the disease is glioblastoma.